ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-Fas Ligand Antibody [B-R17] - BSA and Azide free (A341891)

Mouse monoclonal [B-R17] IVD antibody to Fas Ligand for ELISA, Flow Cytometry and Functional assay.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 10-14 business days.
Name
Anti-Fas Ligand Antibody [B-R17] - BSA and Azide free
Description
Mouse monoclonal [B-R17] IVD antibody to Fas Ligand.
Specificity
This product recognizesAPO1L, Fas ligand (FAS L), a 40 kDa protein.
Applications
ELISA, Flow Cytometry, Functional assay
Reactivity
Human
Immunogen
FasL transfected 293T cell line.
Host
Mouse
Clonality
Monoclonal
Clone ID
B-R17
Myeloma
Source: Myeloma X63/AG.8653 x Balb/c spleen cells
Isotype
Mouse IgG1 Kappa light chain
Conjugate

Unconjugated

Concentration
1.0 mg/mL (+/- 10 %)
Product Form
Liquid
Formulation
Phosphate-buffered saline. Sterile-filtered through 0.22µm. Carrier and preservative free.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
General Notes
For bulk or custom IVD raw material requests, contact us directly.

IVD reagents are supplied in accordance with standard industry lead times of 4-6 weeks. Where products are in stock, dispatch typically occurs within 7-10 business days.
Synonyms
Apoptosis antigen ligand, APT1LG1, APTL, CD178, CD95 ligand, CD95-L, CD95L, Fas antigen ligand, FasL, FASLG, TNFSF6, Tumor necrosis factor ligand superfamily member 6
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Anti-Fas Ligand Antibody [B-R17] - BSA and Azide free (A341891)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-Fas Ligand Antibody [B-R17] - BSA and Azide free (A341891)

Proteins predicted to interact with Fas Ligand

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.9% Relevancy Score
99.8% Relevancy Score
99.8% Relevancy Score
99.2% Relevancy Score
99.1% Relevancy Score